SCHEMBL1032978

SCHEMBL1032978

N#Cc1cccnc1NC1CCNC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.44
ATAD2 Q6PL18 2/20 0.44
RPS6KB1 P23443 2/20 0.43
CHEK1 O14757 2/20 0.42
HPGD P15428 3/20 0.41
ALDH1A1 P00352 3/20 0.41
PDPK1 O15530 1/20 0.41
CCNT1 O60563 1/20 0.40
CCNK O75909 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK9 P50750 1/20 0.40
CDK12 Q9NYV4 1/20 0.40
NRAS P01111 1/20 0.40
FLT3 P36888 1/20 0.40
PRKCI P41743 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032977 1.00 BRD4 (0.44) BRD4ATAD2RPS6KB1CHEK1HPGD
SCHEMBL1034425 0.92 CYP1A2 (0.46) BRD4ATAD2RPS6KB1CHEK1HPGD
SCHEMBL4535545 0.84 HPGD (0.48) HPGDALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL11169214 0.80 KDM4E (0.50) HPGDALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL1035617 0.80 BRD4 (0.48) BRD4ATAD2RPS6KB1CHEK1ALDH1A1
SCHEMBL1035615 0.80 BRD4 (0.48) BRD4ATAD2RPS6KB1CHEK1ALDH1A1
SCHEMBL23708815 0.78 BRD4 (0.47) BRD4ATAD2RPS6KB1CHEK1ALDH1A1
SCHEMBL26620523 0.78 BRD4 (0.47) BRD4ATAD2RPS6KB1CHEK1ALDH1A1
SCHEMBL29994448 0.78 BRD4 (0.47) BRD4ATAD2RPS6KB1CHEK1ALDH1A1
SCHEMBL6509693 0.77 IRAK4 (0.48) RPS6KB1CHEK1HPGDALDH1A1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3030557-B1 A NOVEL PHTALAZINONE DERIVATIVES AND MANUFACTURING PROCESS THEREOF IDIENCE CO LTD (KR) 2023-05-31 EP disclosed
US-RE49338-E1 Phthalazinone derivatives and manufacturing process thereof IDIENCE CO., LTD. (KR) 2022-12-20 US disclosed
CN-105793248-B Phthalazinone derivatives and process for preparing the same 日东制药株式会社 2019-08-16 CN disclosed
US-9844550-B2 Phtalazinone derivatives and manufacturing process thereof ILDONG PHARM CO., LTD (KR) 2017-12-19 US disclosed
US-20170182045-A1 Novel Phtalazinone Derivatives and Manufacturing Process Thereof IL DONG HOLDINGS CO., LTD (KR) 2017-06-29 US disclosed
US-9682973-B2 Phtalazinone derivatives and manufacturing process thereof ILDONG PHARM CO., LTD (KR) 2017-06-20 US disclosed
US-20160222003-A1 Novel Phtalazinone Derivatives and Manufacturing Process Thereof IL DONG HOLDINGS CO., LTD (KR) 2016-08-04 US disclosed
US-8828985-B2 Carbamate and urea inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2014-09-09 US disclosed
US-20130244994-A1 CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 CLAREMON DAVID A (US) 2013-09-19 US disclosed
US-8399504-B2 Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2013-03-19 US disclosed
US-20110112062-A1 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 VITAE PHARMACEUTICALS, INC 2011-05-12 US disclosed
EP-2276730-A2 CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 Vitae Pharmaceuticals, Inc. (US) 2011-01-26 EP disclosed
WO-2009131669-A2 CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222003-A1 Novel Phtalazinone Derivatives and Manufacturing Process Thereof PARP15, PARP10, PARP1 BRD4 1001/4885ATAD2 1531/4885RPS6KB1 2362/4885
US-20130244994-A1 CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD3B1, HSD17B1 BRD4 3497/4885ATAD2 4183/4885RPS6KB1 2382/4885
US-20170182045-A1 Novel Phtalazinone Derivatives and Manufacturing Process Thereof PARP15, PARP10, NUDT5 BRD4 1063/4885ATAD2 1367/4885RPS6KB1 2511/4885
US-20110112062-A1 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSD3B1, HSD17B1 BRD4 3462/4885ATAD2 3297/4885RPS6KB1 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.